For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), dihydropyridine calcium-channel-blocker (DCCB) ...

Bemotrizinol is a newly approved over-the-counter sunscreen active ingredient that offers broad-spectrum protection with low systemic absorption.

Phase 3 ISLEND-1 and ISLEND-2 trials met primary endpoints at week 48, showing a novel, once-weekly oral single-tablet regimen is noninferior to daily B/F/TAF or standard ART.

The phase 3 KEYNOTE-D46/EVOKE-03 study evaluated sacituzumab govitecan/pembrolizumab vs pembrolizumab in untreated PD-L1-high metastatic NSCLC.

Data show that orforglipron, a once-daily oral GLP-1 receptor agonist, drives significant, long-term weight reduction in women with obesity or overweight across all 3 stages of menopause: premenopause ...

Data from the phase 3 BASIS and BASIS KIDS trials support the expanded indication of this once-weekly subcutaneous non-factor therapy down to age 6.

Designed to streamline pharmacy stocking and improve patient access, the compact size features the exact same formulation and cost per mL.

Kennedy and his advisers have been frustrated that federal access to Americans’ medical records has been limited.

The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...

"[These patients] are absent from the diagnostic code that would identify them as long COVID patients." HealthDay News — About 16% of COVID-19 cases develop postacute sequelae of severe acute ...

The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.

A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.